Fitvia Corp.
BRZV · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.44 | -0.15 | -0.29 | -0.11 |
| FCF Yield | -6.97% | -1.94% | -44.50% | -6.27% |
| EV / EBITDA | -63.32 | -38.58 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | 30.38% | 65.04% | 56.86% | 131.81% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 2.77 | 0.43 | 0.39 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -337.16% | -168.50% | -325.64% | 97.10% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | -4.69 | -1.58 | -1.75 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -7.54 | -9.24 | -9.24 | -9.24 |